INR 178.0
(0.0%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 96.66 Million | 230.11 Million | 38.05 Million | 18.22 Million | 116.79 Million | -26.57 Million |
Net Income | 90.16 Million | 149.69 Million | 121.67 Million | 38.75 Million | 10.01 Million | 12.64 Million |
Depreciation & Amortization | 18.99 Million | 15.23 Million | 14.75 Million | 13.75 Million | 13.13 Million | 7.06 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -11.74 Million | 87.48 Million | -109.99 Million | -50.46 Million | 92.3 Million | -47.39 Million |
Other non-cash items | 61.59 Million | -22.29 Million | 11.62 Million | 16.18 Million | 1.34 Million | 1.11 Million |
Investing Cash Flow | -36.14 Million | -134.46 Million | -44.84 Million | -8.27 Million | -39.81 Million | -17.1 Million |
Investments in PPE | -56.22 Million | -115.71 Million | -45.71 Million | -8.46 Million | -40.04 Million | -26.77 Million |
Acquisitions | - | - | - | - | - | 9.55 Million |
Investment purchases | - | -19.41 Million | - | - | - | - |
Sales/Maturities of investments | 20.07 Million | - | - | - | - | - |
Other Investing Activities | -36.02 Million | 664 Thousand | 876 Thousand | 190 Thousand | 227.8 Thousand | 119.02 Thousand |
Financing Cash Flow | 42.65 Million | -95.7 Million | 6.67 Million | -9.92 Million | -76.98 Million | 43.78 Million |
Debt repayment | -48.32 Million | -92.32 Million | -21.01 Million | -17.1 Million | -39.6 Million | -67.21 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -73 Thousand | -3.37 Million | 27.69 Million | 7.17 Million | -37.37 Million | 110.99 Million |
Accounts receivables | -36.38 Million | 9.06 Million | -49.09 Million | -54.5 Million | 76.2 Million | -43.76 Million |
Accounts payables | 4.63 Million | -6.81 Million | 17.44 Million | -2.3 Million | 19.61 Million | 364.12 Thousand |
Inventory | 7.39 Million | 18 Million | -49.19 Million | 46.04 Million | -3.64 Million | -3.99 Million |
Other working capital | 12.61 Million | 67.23 Million | -29.15 Million | -39.69 Million | 139.69 Thousand | - |
Cash at beginning of period | 128 Thousand | 114 Thousand | 218 Thousand | 188 Thousand | 183.6 Thousand | 80.08 Thousand |
Cash at end of period | 103.36 Million | 62 Thousand | 114 Thousand | 218 Thousand | 188.03 Thousand | 183.59 Thousand |
Capital Expenditure | -56.22 Million | -115.71 Million | -45.71 Million | -8.46 Million | -40.04 Million | -26.77 Million |
Effect of forex changes on cash | - | 1000.00 | - | - | -10.00 | -30.00 |
Net cash flow / Change in cash | 103.24 Million | -52 Thousand | -104 Thousand | 30 Thousand | 4430.00 | 103.51 Thousand |
Free Cash Flow | 40.44 Million | 114.39 Million | -7.65 Million | 9.76 Million | 76.75 Million | -53.35 Million |
Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 90.16 Million | 21.71 Million | 25.74 Million | 22.7 Million | 149.69 Million | 24.13 Million |
Depreciation & Amortization | 18.99 Million | 5.47 Million | 4.27 Million | 3.81 Million | 15.23 Million | 3.72 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -11.74 Million | - | - | - | 87.48 Million | - |
Other non-cash items | 61.59 Million | -5.47 Million | -4.27 Million | -3.81 Million | -22.29 Million | -3.72 Million |
Investing Cash Flow | -36.14 Million | - | - | - | -134.46 Million | - |
Investments in PPE | -56.22 Million | - | - | - | -115.71 Million | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | -19.41 Million | - |
Sales/Maturities of investments | 20.07 Million | - | - | - | - | - |
Other Investing Activities | - | - | - | - | 664 Thousand | - |
Financing Cash Flow | 42.65 Million | - | - | - | -95.7 Million | - |
Debt repayment | -48.32 Million | - | - | - | -92.32 Million | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -73 Thousand | - | - | - | -3.37 Million | - |
Accounts receivables | -36.38 Million | - | - | - | 9.06 Million | - |
Accounts payables | 4.63 Million | - | - | - | -6.81 Million | - |
Inventory | 7.39 Million | - | - | - | 18 Million | - |
Other working capital | 12.61 Million | - | - | - | 67.23 Million | - |
Cash at beginning of period | 128 Thousand | 221 Thousand | -25.52 Million | 128 Thousand | 114 Thousand | -24 Million |
Cash at end of period | 103.36 Million | 21.71 Million | 221 Thousand | 22.7 Million | 62 Thousand | 128 Thousand |
Capital Expenditure | -56.22 Million | - | - | - | -115.71 Million | - |
Effect of forex changes on cash | - | - | - | - | 1000.00 | - |
Net cash flow / Change in cash | 103.24 Million | 21.49 Million | 25.74 Million | 22.57 Million | -52 Thousand | 24.13 Million |
Free Cash Flow | 40.44 Million | 21.71 Million | 25.74 Million | 22.7 Million | 114.39 Million | 24.13 Million |
7685
4689
UMGP
GSK
DHANUKA
AMNZF